EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma

Shoichi Fumoto1, Keiko Hiyama, Keiji Tanimoto

  • 1Department of Translational Cancer Research, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima 734-8551, Japan.

Cancer Letters
|October 1, 2008
PubMed

Insights

Epithelial membrane protein 3 (EMP3) acts as a tumor suppressor in esophageal squamous cell carcinoma (ESCC). Lower EMP3 expression in ESCC patients correlates with poorer survival, suggesting its role in late-stage cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Epithelial membrane protein 3 (EMP3) has been identified as a tumor suppressor in neuroblastomas and gliomas.
  • Esophageal squamous cell carcinoma (ESCC) is a significant global health concern with a need for better understanding of its molecular drivers.

Purpose of the Study:

  • To investigate the role of EMP3 in the development and progression of ESCC.
  • To determine the mechanisms underlying EMP3 repression in ESCC.
  • To evaluate the prognostic value of EMP3 expression in ESCC patients.

Main Methods:

  • Oligonucleotide microarrays were used to identify commonly repressed genes in ESCC cell lines.
  • EMP3 overexpression was induced in ESCC cell lines to assess its effects on cell growth and morphology.
  • TERT expression levels were measured following EMP3 overexpression.
  • The impact of trichostatin A (TSA) on EMP3 expression was examined to investigate the role of histone deacetylases.
  • Correlation between EMP3 expression levels and patient survival post-surgery was analyzed.

Main Results:

  • EMP3 was found to be commonly repressed in ESCC cell lines.
  • Overexpression of EMP3 in ESCC cells led to growth inhibition and morphological changes.
  • EMP3 overexpression resulted in the repression of TERT.
  • EMP3 repression was observed to be associated with promoter hypermethylation and histone deacetylase activity.
  • Lower EMP3 expression in ESCC patients was linked to poorer post-recurrence survival after radical surgery.

Conclusions:

  • EMP3 functions as a tumor suppressor gene in ESCC.
  • EMP3 repression, potentially through epigenetic mechanisms including hypermethylation and histone deacetylase activity, contributes to ESCC development.
  • EMP3 expression level is a potential prognostic biomarker for ESCC patients undergoing radical surgery.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...